Pegasys and Copegus for Asian patients with treatment-naive hepatitis C genotypes 6, 7, 8, 9: a phase IV, randomized, open-labeled, multicenter trial comparing 24-week vs. 48-week therapy.
Phase of Trial: Phase IV
Latest Information Update: 01 Nov 2010
At a glance
- Drugs Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 17 Dec 2009 Actual end date (1 Sep 2009) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jan 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History